GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Apollomics Inc (NAS:APLMW) » Definitions » Additional Paid-In Capital

Apollomics (Apollomics) Additional Paid-In Capital : $661.47 Mil(As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Apollomics Additional Paid-In Capital?


Apollomics's quarterly additional paid-in capital increased from Dec. 2022 ($12.28 Mil) to Jun. 2023 ($661.47 Mil) and increased from Jun. 2023 ($661.47 Mil) to Dec. 2023 ($661.47 Mil).

Apollomics's annual additional paid-in capital increased from Dec. 2021 ($11.89 Mil) to Dec. 2022 ($12.28 Mil) and increased from Dec. 2022 ($12.28 Mil) to Dec. 2023 ($661.47 Mil).

Apollomics Additional Paid-In Capital Historical Data

The historical data trend for Apollomics's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Apollomics Additional Paid-In Capital Chart

Apollomics Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Additional Paid-In Capital
11.75 11.89 12.28 661.47

Apollomics Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Additional Paid-In Capital Get a 7-Day Free Trial 11.89 12.04 12.28 661.47 661.47

Apollomics Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Apollomics Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Apollomics's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Apollomics (Apollomics) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Apollomics Inc (NAS:APLMW) » Definitions » Additional Paid-In Capital
Comparable Companies
ATHA STTK ACXP CARA TLSA ORMP IMMX CCCC GTHX GBIO OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
APLM:USA
Address
989 East Hillsdale Boulevard, Suite 220, Foster, CA, USA, 94404
Website
https://www.apollomicsinc.com
Apollomics Inc is an innovative clinical-stage biotechnology company. It is is focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. It has a pipeline of 9 drug candidates across multiple programs, 6 of which are in the clinical stage of development.